Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review

被引:3
|
作者
Lai, Kuan-Chang [2 ]
Hsiao, Yi-Han [1 ]
Chen, San-Chi [3 ]
机构
[1] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Ctr Immunooncol, Dept Oncol, Div Med Oncol, Taipei, Taiwan
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
Pulse corticosteroid therapy; steroid-refractory; immune checkpoint inhibitors; pneumonitis; immune-related adverse event; nivolumab;
D O I
10.3389/fimmu.2022.994064
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune checkpoint inhibitors (ICIs) have demonstrated promising therapeutic outcomes in treating a variety of malignancies, but immune-related adverse events (irAE) may develop. Among all the irAE, immune-related pneumonitis was relatively common and life-threatening. High-dose corticosteroid was recommended for the initial management, but a part of patients developed steroid-refractory pneumonitis. Other immunosuppressants were recommended, but the optimal treatment is still controversial. Here, we report two cases of steroid-refractory immune-related pneumonitis who were successfully treated with pulse corticosteroid therapy. Case 1 was hepatocellular carcinoma treated with nivolumab for 5 months. She developed acute respiratory distress syndrome due to grade 4 immune-related pneumonitis that was refractory to intravenous methylprednisolone 2 mg/kg/day treatment. Methylprednisolone 500 mg for 3 days followed by 2 mg/kg/day steroid as maintenance therapy was given. Subsequently, her pneumonitis was regressed, and the endotracheal tube was successfully removed on day 9 after the start of pulse therapy. Case 2 presented with grade 4 immune-related pneumonitis in spite the use of methylprednisolone 1 mg/kg for his skin rash. Pulse corticosteroid therapy was prescribed, then his pneumonitis was completely regressed on day 12. In this report, we demonstrated the potential role of pulse corticosteroid therapy for steroid-refractory pneumonitis.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Successful treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis with triple combination therapy: a case report
    Utsumi, Hirofumi
    Araya, Jun
    Okuda, Keitaro
    Watanabe, Junko
    Takekoshi, Daisuke
    Fujita, Yu
    Hashimoto, Mitsuo
    Wakui, Hiroshi
    Minagawa, Shunsuke
    Numata, Takanori
    Hara, Hiromichi
    Kuwano, Kazuyoshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2033 - 2039
  • [2] Successful treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis with triple combination therapy: a case report
    Hirofumi Utsumi
    Jun Araya
    Keitaro Okuda
    Junko Watanabe
    Daisuke Takekoshi
    Yu Fujita
    Mitsuo Hashimoto
    Hiroshi Wakui
    Shunsuke Minagawa
    Takanori Numata
    Hiromichi Hara
    Kazuyoshi Kuwano
    Cancer Immunology, Immunotherapy, 2020, 69 : 2033 - 2039
  • [3] Infliximab in the treatment of tislelizumab-induced steroid-refractory immune checkpoint inhibitor-related pneumonia: case report and literature review
    Chen, Zhujun
    He, Jian
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (09) : 3309 - 3314
  • [4] Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review
    Wang, Yang
    Li, Shouchao
    Shi, He
    Guan, Xue
    Wei, Qiang
    Chen, Dazhong
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (04)
  • [5] Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
    Gerard, Alexandre
    Romani, Serena
    Van-Obberghen, Elise
    Fresse, Audrey
    Muzzone, Marine
    Parassol, Nadege
    Boscagli, Annick
    Rocher, Fanny
    Borchiellini, Delphine
    Drici, Milou-Daniel
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review
    Wang, Yuan-Di
    Yuan, Shengfang
    Wen, Cuiling
    Ji, Zexuan
    Xiang, Baoli
    Wang, Bu
    Zhang, Zhihua
    IMMUNOTHERAPY, 2023, 15 (14) : 1117 - 1123
  • [7] A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
    Guan, Shasha
    Zhang, Linlin
    Zhang, Junyan
    Song, Wenjing
    Zhong, Diansheng
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [8] Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature
    Li, Ling
    Lou, Anqi
    Yu, Junxian
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 8460 - 8466
  • [9] Immune Checkpoint Inhibitor-Related Pneumonitis
    Gomatou, Georgia
    Tzilas, Vasilios
    Kotteas, Elias
    Syrigos, Konstantinos
    Bouros, Demosthenes
    RESPIRATION, 2021, 99 (11) : 932 - 942
  • [10] Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review
    Pan, Lei
    Meng, Fanqi
    Wang, Wei
    Wang, Xu-hao
    Shen, Hui
    Bao, Pengchen
    Kang, Jian
    Kong, Delei
    FRONTIERS IN IMMUNOLOGY, 2023, 13